First Time Loading...

Atreca Inc
NASDAQ:BCEL

Watchlist Manager
Atreca Inc Logo
Atreca Inc
NASDAQ:BCEL
Watchlist
Price: 0.0921 USD 2.33% Market Closed
Updated: Jun 1, 2024

Atreca Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Atreca Inc
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Atreca Inc
NASDAQ:BCEL
Accounts Payable
$1.7m
CAGR 3-Years
-7%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$31.3B
CAGR 3-Years
15%
CAGR 5-Years
22%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
$622m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$1.6B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$351.4m
CAGR 3-Years
40%
CAGR 5-Years
34%
CAGR 10-Years
22%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$671.3m
CAGR 3-Years
7%
CAGR 5-Years
23%
CAGR 10-Years
35%

See Also

What is Atreca Inc's Accounts Payable?
Accounts Payable
1.7m USD

Based on the financial report for Dec 31, 2022, Atreca Inc's Accounts Payable amounts to 1.7m USD.

What is Atreca Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
23%

Over the last year, the Accounts Payable growth was -50%. The average annual Accounts Payable growth rates for Atreca Inc have been -7% over the past three years , 23% over the past five years .